Indian company Ranbaxy Laboratories is being sued by a New Jersey man over its decision to recall a generic version of the cholesterol medication Lipitor because glass particles were found in some lots.
According to a report on Pharmalot, the recall was made only at the pharmacy level, which means consumers were not directly notified of the problem or how to respond if they became aware of it. The New Jersey ...
continue reading...The U.S. Food and Drug Administration recently added warnings to the labels of widely used cholesterol drugs called statins, which include Pfizer Inc.’s Lipitor. The new labels warn that the drugs may raise blood sugar levels, could cause memory loss, and may increase the risk of Type II diabetes.
According to a Reuters story, researchers with the University of Massachusetts Medical School in Worchester drew data from the Women’s Health Initiative, which included more than 150,000 diabetes-free women in their 50s, ...
continue reading...The India-based manufacturer of a generic version of cholesterol medication Lipitor has issued a recall after tiny pieces of glass were found in some of its tablets.
The medication in question is called Atorvastatin, made by Ranbaxy Pharmaceuticals Inc., according to an ABC News report.
The U.S. Food and Drug Administration announced that the company will halt production of Atorvastatin “until it has thoroughly investigated the cause of the glass particulates and remedied the problem.”
The report says that the glass particles discovered ...
continue reading...
